Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

EnPro (NPO) Announces Divestment Of Brake Business To MAT HD

Published 09/26/2019, 09:46 PM
Updated 07/09/2023, 06:31 AM

In sync with the portfolio-transformation strategy, EnPro Industries, Inc. (NYSE:NPO) recently announced the divesture of the Rome, GA-based brake business to MAT HD, LLC., a subsidiary of MAT Holdings, Inc. Notably, the financial terms of the transaction are still kept under wraps.

MAT Holdings is engaged in manufacturing, marketing, and distributing diversified products in several industries including automotive and power equipment. Notably, this Long Grove, IL-based company’s operations are spread across three continents — North America, Europe and Asia. Founded in 1984, MAT Holdings employs more than 15,000 people throughout the world.

As part of EnPro’s STEMCO business unit, the brake business is a producer of high-quality brake shoes, lined brake shoes, and wheel kits for medium and heavy-duty truck applications.

As a matter of fact, the divestment of the business will enable EnPro to focus more on core businesses. In addition, the divestment will allow MAT Holdings to strengthen its offerings in the heavy-duty product portfolio.

Other Inorganic Moves

A notable inorganic move by the company was the acquisition of LeanTeq Co., Ltd. this month. Notably, the acquired assets will be integrated with the Technetics division of its Sealing Products segment.

This buyout will help EnPro in strengthening Technetics’ operations by boosting its manufacturing capabilities, product offerings and technological knowhow, along with strengthening the aftermarket business.

This apart, the company completed the buyout of a privately-held company — The Aseptic Group — in July 2019. Notably, EnPro integrated the acquired assets with the Garlock division of its Sealing Products segment. The buyout is likely to boost Garlock’s operations by strengthening product offerings and manufacturing capabilities, and expanding in biopharmaceutical and pharmaceutical industries.

EnPro currently carries a Zacks Rank #3 (Hold). In the past three months, the stock has increased 6% against the industry’s decline of 1.9%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Stocks to Consider

Some better-ranked stocks from the same space are Crawford United Corporation (OTC:CRAWA) , Chart Industries, Inc. (NASDAQ:GTLS) and Graham Corporation (NYSE:GHM) . While Crawford sports a Zacks Rank #1 (Strong Buy), Chart Industries and Graham carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Crawford delivered average positive earnings surprise of 10.08% in the trailing four quarters.

Chart Industries delivered average positive earnings surprise of 13.87% in the trailing four quarters.

Graham’s earnings surprise in the last reported quarter was 100.00%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



EnPro Industries (NPO): Free Stock Analysis Report

Chart Industries, Inc. (GTLS): Free Stock Analysis Report

Graham Corporation (GHM): Free Stock Analysis Report

Hickok Inc. (CRAWA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.